Author:
Long John P.,Prout George R.
Reference24 articles.
1. Heller J.E., Prostatic acid phosphatase, Its current clinical status, J. Urol. 137:1091 (1987).
2. Paulson D.F., Berry W.R, et. al., Treatment of metastatic endocrine-unresponsive carcinoma of the prostate gland with multiagent chemotherapy: Indicators of response to therapy, J.N.C.I. 63:615 (1979).
3. Sogani P.C., Vagaiwala M.R. and Whitmore, W.T., Experience with flutamide in patients with advanced prostatic cancer without prior endocrine therapy, Cancer 54:744 (1984).
4. Johnson D.E., Scott W.W., et. al., Clinical significance of serum acid phosphatase levels in advanced prostatic carcinoma, Urology 8:123 (1976).
5. El-Shirbiny A., Bhargava A., et. al., Comparison of immunologic and enzymatic assay of prostatic acid phosphatase for follow-up and assessment of clinical status of stage D prostate cancer, J. Surg. Onc. 26:256 (1984).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. TUMOR MARKERS;Medical Clinics of North America;1996-01